Mind Medicine (MindMed) Investor Relations Material
Latest events
Study Update
Mind Medicine (MindMed)
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Mind Medicine (MindMed) Inc
Access all reports
Mind Medicine, Inc. operates as a psychedelic medicine biotech company. They focus on discovering, developing, and deploying psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine's research management team is led by Jim DeKorne in Oakland, CA. Jim has discovered uses for psychedelics in a diverse range of fields since the 1960s. These healthcare applications span illness management and palliative care to prevention strategies in psychiatry and drug abuse treatment. The Company is also exploring treatments for post-traumatic stress disorder (PTSD), as well as to optimize performance in individuals engaged in occupations requiring focus, problem solving, and creative abilities, such as medical workers, pilots, nuclear facility technicians, and first responders. Mind Medicine intends to conduct clinical trials leading to Federal Drug Administration approval of its lead candidate MindMed™—a combination of psychotherapy with the non-hallucinogenic fractionated doses of DMT.
Key slides for Mind Medicine (MindMed) Inc
Study Update
Mind Medicine (MindMed) Inc
Study Update
Mind Medicine (MindMed) Inc
Latest articles
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Companies That Had Their IPO in 2022: War, Inflation and Interest Rates
The stock market and IPO landscape in 2022 was marked by inflationary pressures, rate hikes, and war that heavily impacted the market sentiment.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States